FdaApplication
ANDA 204613
Identifiers
- fda_app_no: ANDA204613
Properties
| Property | Value |
|---|---|
| applicant_name | ALTAIRE PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2018-05-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CIPROFLOXACIN HYDROCHLORIDE | CIPROFLOXACIN HYDROCHLORIDE | EQ 0.3% BASE | SOLUTION/DROPS;OPHTHALMIC |
1 product